UK biotech firm Synairgen surged as much as 552% on Monday after the company announced its experimental coronavirus drug helped curb the contraction of serious COVID-19 symptoms. The SNG001 drug cut the odds of a patient requiring ventilation or dying by 79% compared to those receiving a placebo, the company […]
Moderna stock surged as much as 17% in early Wednesday trading after the company announced an early coronavirus vaccine trial produced antibodies in all participants. A range of dosages induced immune responses in all 45 Phase 1 trial patients and was “generally safe and well-tolerated,” Moderna said in a press […]
Pfizer shares soared as much as 7.2% on Wednesday after the company announced positive early-stage trial results for its coronavirus vaccine. The BNT162b1 drug successfully created antibodies in all participants receiving 10, 30, or 100 microgram doses. Those taking two of the 10 or 30 microgram doses created between 1.8 […]
Pfizer stock plummeted as much as 8.2% on Monday after the company halted a phase 3 breast-cancer treatment trial. The pharmaceutical giant’s palbociclib treatment was “unlikely to show a statistically significant improvement” in survival rates, according to a statement made after Friday’s market close. Monday’s decline was the largest drag […]
The World Health Organisation announced a pause in hydroxychloroquine trials at a Monday press conference. The steering committee of the study met over the weekend and agreed to suspend enrollment while gathering data about the safety and efficacy of the drug. The study was part of the “Solidarity” trial launched […]
Gilead stock plunged as much as 9% on Thursday after STAT News reported its experimental coronavirus drug remdesivir failed to improve patient conditions in a clinical trial. A summary of the trial’s results was mistakenly uploaded to the WHO’s website, STAT reported. The report contained “inappropriate characterizations of the study,” […]